This website is intended for healthcare professionals only

ANZBMS 2022 – Introducing a New Era in The Management of XLH

Part 2 - The safety and efficacy of Crysvita in Paediatrics

More Videos

The 10th Pediatric Endocrine Update 2022 : Highlights in Pediatric Endocrinology

New Insights in X-Linked Hypophosphatemic Rickets

11th Asia Pacific Endocrine Society 2021 (APPES 2021) in Conjunction with the 42nd Malaysian Pediatric Association Annual Congress 2021

Phosphorus – The Forgotten Mineral for Strong Bone

Website developed and funded by Kyowa Kirin Asia Pacific Pte. Ltd. © 2024 Kyowa Kirin Asia Pacific Pte. Ltd. SG-CRV-22-00006 AUG2024

logo-crysvita

This website is for healthcare professionals only, please login below or

Welcome to Crysvita.Asia website!

Crysvita.Asia website is a branded website to deepen the understanding of healthcare professionals on the treatment and management of X-Linked Hypophosphatemia (XLH) and Crysvita® (Burosumab).

It showcases results from clinical trials and treatment management, as well as useful information, resources, links and contact information.

Login below or create an account to get all the latest updates on XLH and Crysvita (Burosumab) from this website:

logo_header_01
logo-crysvita
logo-crysvita.png
logo-crysvita.png
logo-crysvita.png
logo-crysvita.png
logo-crysvita-1.png
You will be accessing an external site. Click “OK” to continue.